Machine Learning in Biotechnology: A Working Reference Machine learning, at its core, is just a branch of artificial intelligence where a system gets better at a task by being shown examples, rather than by someone writing out every rule in advance. Biotechnology, meanwhile, is the practice of putting living systems cells, enzymes, entire organisms to work solving practical problems. Put the two together and you get something like this: algorithms trained on genomic sequences, protein structures, metabolic profiles, and imaging data, being used to speed up decisions that used to take a postdoc several years of bench work to arrive at. That's the short version. The longer version is messier, and worth sitting with for a moment. Biological data doesn't behave like the clean, well-labeled datasets that made image recognition and language models possible. It's noisy, it's expensive to generate, and a single experiment might produce more dimensions than there are sample...
Adaptive Biotechnologies: Pioneering the Future of Immune-Driven Medicine Adaptive Biotechnologies stands at the forefront of a revolutionary paradigm in healthcare: leveraging the power and specificity of the adaptive immune system to diagnose and treat a vast spectrum of diseases. By decoding the intricate language of T-cell and B-cell receptors, Adaptive is unlocking unprecedented insights into immune responses, paving the way for personalized and highly effective therapeutic interventions. Unveiling the Immune Repertoire: Foundational Technology At the core of Adaptive's innovation is its proprietary immune sequencing technology. This sophisticated platform precisely identifies and quantifies the unique T-cell receptor (TCR) and B-cell receptor (BCR) sequences present in a patient's blood or tissue. Each TCR and BCR acts as a molecular fingerprint, representing the immune system's historical and ongoing encounters with pathogens, cancers, and autoimmune triggers. This...